Medicines Transparency Alliance
28 August 2008 | HOME

REGISTER

 

 

 

Department for International Development

Welcome to MeTA

Medicines Transparency Alliance (MeTA) is a multi-stakeholder alliance working to improve access and affordability of medicines for the one third of the world’s population unable to access basic and essential medicines due to high cost or local unavailability.

Medicine supply is affected through numerous stages in the complex process of getting any given medicine to the patient: selection, regulation, procurement, sale, distribution, prescribing, promotion and use are critical stages in health commodity provision - all of which have to function efficiently to ensure access to the end user. MeTA aims to increase the transparency and accountability of the healthcare marketplace throughout this pathway from medicine production and import, to patient use.

Because of the complexity of the health commodities supply chain, MeTA works via cooperation across a diverse range of stakeholders with interests in the pharmaceutical sector at international and national levels. MeTA brings together these stakeholders for the first time, and strengthens national capacity to collect, analyse, disclose and apply data influencing medicine procurement, promotion and supply.

Countries that implement MeTA make a commitment to disclosing a set of core data on the quality, availability, price and promotion of medicines. This process fully involves civil society, business and public sectors to identify and address the functioning of the pharmaceutical market.

Read More...

 

Latest News

DFID consultation for Access to Medicines Research Network. Online survey available 1-30 June. Find out more...